We are live on ! Find out more
MIP

Mondrian Investment Partners Portfolio holdings

AUM $6.48B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+18.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.5B
AUM Growth
-$42M
Cap. Flow
-$301M
Cap. Flow %
-6.68%
Top 10 Hldgs %
48.23%
Holding
152
New
9
Increased
69
Reduced
36
Closed
13

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$255M
2
MON
Monsanto Co
MON
+$58.1M
3
MA icon
Mastercard
MA
+$34.4M
4
SYF icon
Synchrony
SYF
+$21.6M
5
CAE icon
CAE Inc. Common Shares
CAE
+$16.6M

Sector Composition

Rank Sector Weight
1 Financials 18.79%
2 Technology 17.87%
3 Healthcare 14.38%
4 Communication Services 12.27%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBMH
151
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
-9,912
Closed -$33K
PMCS
152
DELISTED
P M C SIERRA INC
PMCS
-5,257
Closed -$61K

Similar funds

Mondrian Investment Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Mondrian Investment Partners held 152 positions worth $4.5B, down 0.92% from $4.55B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Mondrian Investment Partners withdrew a net $301M in Q1 2016, closing 13 positions and reducing 36 holdings. Its most notable exit was MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A, an estimated $286M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Mondrian Investment Partners opened a new position in Abbott worth $269M.

  • Mondrian Investment Partners's largest Q1 2016 buy was Abbott: 6,426,540 shares worth $269M.
  • Mondrian Investment Partners added most to Mastercard in Q1 2016, an estimated $34.4M increase.
  • Mondrian Investment Partners's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $68.3M.
  • Mondrian Investment Partners fully exited MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2016, selling an estimated $286M.
  • Mondrian Investment Partners's ten largest holdings make up 48% of its $4.5B portfolio in Q1 2016.
  • Mondrian Investment Partners opened 9 new positions and closed 13 in Q1 2016.
  • Mondrian Investment Partners's portfolio value fell 0.92% quarter-over-quarter to $4.5B.

Based on Mondrian Investment Partners's 13F filing for Q1 2016, filed 4 May 2016.